August 27, 2020 08:42
The Ministry of Food and Drug Safety on Tuesday approved a phase one clinical trial of a coronavirus vaccine being developed by pharmaceutical company Celltrion.
According to the company, researchers can now administer CT-P59 to nine patients with mild coronavirus symptoms in Korea and another nine in U.K.
CT-P59 is a genetically modified antibody treatment that the company is developing. It is the first to receive clinical approval in Korea.
- Copyright © Chosunilbo & Chosun.com